AnGes Inc

AJW

Company Profile

  • Business description

    AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.

  • Contact

    7-7-15, Saito-asagi
    4F, Saito Bio-Incubator
    Ibaraki
    Osaka567-0085
    JPN

    http://www.anges.co.jp

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    71

Stocks News & Analysis

stocks

Oracle shares are up 87% in 2025. Is it a buy?

Oracle’s cloud database business is riding the AI wave.
stocks

Bumper crop to benefit ASX listed share

We raise our earnings forecast 11% for next year.
stocks

Is there a long-term buying opportunity in luxury stocks?

Our analysts think the recent wobble in revenue growth is cyclical, not structural.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,102.1011.700.13%
CAC 407,830.1123.48-0.30%
DAX 4023,527.05112.36-0.48%
Dow JONES (US)46,410.5495.270.21%
FTSE 1009,226.6810.010.11%
HKSE26,344.14200.96-0.76%
NASDAQ22,791.16159.680.71%
Nikkei 22545,493.66447.850.99%
NZX 50 Index13,141.5490.12-0.68%
S&P 5006,697.3332.970.49%
S&P/ASX 2008,810.9011.400.13%
SSE Composite Index3,828.588.490.22%

Market Movers